BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Detailed News
Back
Venmax Drugs & Pharmaceuticals reports standalone net profit of Rs 0.03 crore in the December 2025 quarter
07-Feb-26   18:17 Hrs IST

Net profit of Venmax Drugs & Pharmaceuticals reported to Rs 0.03 crore in the quarter ended December 2025 as against net loss of Rs 0.50 crore during the previous quarter ended December 2024. Sales rose 675.00% to Rs 1.55 crore in the quarter ended December 2025 as against Rs 0.20 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales1.550.20 675
OPM %-1.94-250.00 -
PBDT0.04-0.50 LP
PBT0.04-0.50 LP
NP0.03-0.50 LP

Powered by Capital Market - Live News
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, developed & powered by C-MOTS Infotech (ISO 9001:2015 certified)